• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

46例前列腺癌中1、7、8、10、18号染色体及Y染色体的增减情况

Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers.

作者信息

König J J, Teubel W, Romijn J C, Schröder F H, Hagemeijer A

机构信息

Department of Urology, Erasmus University, Rotterdam, The Netherlands.

出版信息

Hum Pathol. 1996 Jul;27(7):720-7. doi: 10.1016/s0046-8177(96)90404-9.

DOI:10.1016/s0046-8177(96)90404-9
PMID:8698318
Abstract

Fluorescence in situ hybridization (FISH) with centromere probes was used to investigate numerical aberrations of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate carcinoma (PC) and 11 benign prostatic hyperplasia (BPH) samples. None of the benign specimens showed any chromosomal aberration. Forty-one of 46 PC specimens showed numerical aberrations of one or more chromosomes. All investigated chromosomes showed numerical aberrations in at least 30% of the specimens, gain being more frequent than loss. Comparison of DNA flow cytometry (FCM) and FISH results showed that not only aneuploid tumors but also most diploid tumors harbored numerical chromosome aberrations. Chromosome 10 was the most frequently gained (65%), and Y the most frequently lost chromosome (14%). Nonmetastatic and metastatic tumors differed significantly (P < .05) in the number of copies for chromosomes 7, 8, and 10, but not for 1, 18, and Y. These results suggest strongly that gains of chromosomes 7, 8, and 10 are involved in PC progression.

摘要

采用着丝粒探针进行荧光原位杂交(FISH),以研究46例前列腺癌(PC)和11例良性前列腺增生(BPH)样本中1、7、8、10、18号染色体及Y染色体的数目畸变情况。所有良性样本均未显示任何染色体畸变。46例PC样本中有41例显示一条或多条染色体的数目畸变。所有研究的染色体在至少30%的样本中显示数目畸变,增加比丢失更常见。DNA流式细胞术(FCM)和FISH结果比较显示,不仅非整倍体肿瘤,而且大多数二倍体肿瘤也存在染色体数目畸变。10号染色体是最常增加的(65%),Y染色体是最常丢失的(14%)。非转移性和转移性肿瘤在7、8和10号染色体的拷贝数上有显著差异(P < 0.05),但在1、18号染色体及Y染色体上无差异。这些结果强烈提示,7、8和10号染色体的增加与PC进展有关。

相似文献

1
Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers.46例前列腺癌中1、7、8、10、18号染色体及Y染色体的增减情况
Hum Pathol. 1996 Jul;27(7):720-7. doi: 10.1016/s0046-8177(96)90404-9.
2
Loss and gain of chromosomes 1, 18, and Y in prostate cancer.前列腺癌中1号、18号染色体及Y染色体的缺失与增益
Prostate. 1994 Dec;25(6):281-91. doi: 10.1002/pros.2990250602.
3
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.通过荧光原位杂交技术对前列腺癌染色体拷贝数畸变进行灵敏检测。
Am J Pathol. 1994 Sep;145(3):624-30.
4
Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.前列腺肿瘤进展的间期细胞遗传学:特定染色体异常与骨转移有关。
Lab Invest. 1997 Nov;77(5):437-48.
5
Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases.前列腺癌的间期细胞遗传学:日本病例的荧光原位杂交(FISH)分析
Br J Cancer. 1996 Dec;74(11):1699-704. doi: 10.1038/bjc.1996.617.
6
Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: fluorescence in situ hybridization analysis of 5 Japanese cases.抗雄激素治疗后转移性前列腺癌的染色体数值变化:5例日本病例的荧光原位杂交分析
Cancer Genet Cytogenet. 2000 Jul 15;120(2):148-54. doi: 10.1016/s0165-4608(00)00208-9.
7
Numeric alterations in chromosomes 7 and 8 detected by fluorescent in situ hybridization correlate with high-grade localized prostate cancer.通过荧光原位杂交检测到的7号和8号染色体的数值改变与高级别局限性前列腺癌相关。
Eur Urol. 1998;34(5):419-25. doi: 10.1159/000019776.
8
Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.前列腺癌细胞遗传学异常的纵向评估:随时间复发的肿瘤显示出非持续性肿瘤和转移性肿瘤之间的中间遗传状态。
J Pathol. 1998 Jul;185(3):273-83. doi: 10.1002/(SICI)1096-9896(199807)185:3<273::AID-PATH92>3.0.CO;2-8.
9
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.通过荧光原位杂交检测到的8号和Y染色体的非整倍体是病理分期为C期(pt3N0M0)前列腺癌的预后标志物。
Clin Cancer Res. 1996 Jan;2(1):137-45.
10
Fluorescence in situ hybridization to assess transitional changes of aneuploidy for chromosomes 7, 8, 10, 12, 16, X and Y in metastatic prostate cancer following anti-androgen therapy.荧光原位杂交技术用于评估抗雄激素治疗后转移性前列腺癌中7号、8号、10号、12号、16号染色体以及X和Y染色体非整倍体的转变情况。
Int J Oncol. 2001 Sep;19(3):543-9. doi: 10.3892/ijo.19.3.543.

引用本文的文献

1
Effectiveness of intraoperative cell salvage combined with a modified leucocyte depletion filter in metastatic spine tumour surgery.术中细胞回收联合改良白细胞滤器在转移性脊柱肿瘤手术中的有效性。
BMC Anesthesiol. 2022 Jul 12;22(1):217. doi: 10.1186/s12871-022-01743-0.
2
A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome.原发性前列腺肿瘤中 18q 的拷贝数增益与转移结果相关。
Urol Oncol. 2020 Dec;38(12):932.e1-932.e7. doi: 10.1016/j.urolonc.2020.06.015. Epub 2020 Jul 12.
3
Sexual dimorphism in cancer.
癌症中的性别二态性。
Nat Rev Cancer. 2016 May;16(5):330-9. doi: 10.1038/nrc.2016.30. Epub 2016 Apr 15.
4
Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lymphocytes.鉴定出一种源自CML66的表位,CML66是一种在人类白血病中广泛表达的新型肿瘤相关抗原,可被人类白细胞抗原-A*2402限制性细胞毒性T淋巴细胞识别。
Cancer Sci. 2008 Jul;99(7):1414-9. doi: 10.1111/j.1349-7006.2008.00823.x. Epub 2008 Apr 16.
5
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.CML66是一种具有广泛免疫原性的肿瘤抗原,可引发与慢性粒细胞白血病缓解相关的体液免疫反应。
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7492-7. doi: 10.1073/pnas.131590998.